Melanoma Dispatch
2.7K views | +0 today
Follow
News for Patients and Physicians
Curated by Cancer Commons
Your new post is loading...
Your new post is loading...
Rescooped by Cancer Commons from Lung Cancer Dispatch
Scoop.it!

Myc-Driven Tumors Could be Next for Targeted Therapies

Myc-Driven Tumors Could be Next for Targeted Therapies | Melanoma Dispatch | Scoop.it

Scientists have made a breakthrough in inhibiting the tumor-driving protein myc, which previously had been impossible to target with drugs. Myc drives cells toward uncontrolled growth in tumors, and is involved in many of the most serious forms of cancer, including breast cancer, lung cancer, colorectal cancer, brain cancer, prostate cancer, and blood cancer. Scientists have found that one drug that indirectly targets myc slows tumor growth in a mouse model of myc-driven cancer. The key to the breakthrough was recognizing that myc relies partially on MTOR, another protein, for its protein supply. By targeting MTOR, the drug keeps myc from promoting tumor growth. The drug, called MLN0128, is already in clinical trials for a variety of cancers, but this is the first time it has been viewed as a tool to treat myc-driven cancer. The researchers said that other indirect targeted therapy drugs are already being tested in human studies to treat myc-driven tumors.

Cancer Commons's insight:

Science Daily | Jul 19, 2013

more...
Cancer Commons's curator insight, July 19, 2013 2:39 PM

Science Daily | Jul 19, 2013

Cancer Commons's curator insight, July 19, 2013 6:11 PM

Science Daily | Jul 19, 2013

Cancer Commons's curator insight, July 19, 2013 6:11 PM

Science Daily | Jul 19, 2013

Rescooped by Cancer Commons from Lung Cancer Dispatch
Scoop.it!

'iKnife' Could Revolutionize Cancer Surgery

'iKnife' Could Revolutionize Cancer Surgery | Melanoma Dispatch | Scoop.it

A new surgical tool–dubbed the 'iKnife'–has the potential to change the way surgeons operate on cancer patients. Typically, surgeons use knives that vaporize tumors during procedures, which produces a strong-smelling smoke. Under standard protocol the surgeon must send tissue to the lab to be analyzed to determine whether or not it is cancerous, waiting on the results while the patient lies on the operating table for close to 30 minutes. The 'iKnife' eliminates the lab work, analyzing the smoke on its own to distinguish cancerous tissue from healthy tissue; it can tell doctors if the tissue is cancerous almost instantaneously. In a recent study, the knife correctly detected cancer in all 91 patients. Researchers believe the knife will lower tumor recurrence rates and enable more accurate procedures.

Cancer Commons's insight:

CBS News | Jul 17, 2013

more...
Cancer Commons's curator insight, July 19, 2013 2:14 PM

CBS News | Jul 17, 2013

Cancer Commons's curator insight, July 19, 2013 6:06 PM

CBS News | Jul 17, 2013

Cancer Commons's curator insight, July 19, 2013 6:06 PM

CBS News | Jul 17, 2013